CLINICAL_TRIALS
trial_result
· 2011-03-23
Clinical Trial Update: Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS) [Phase 2]
Summary
Phase 2 clinical trial evaluating the efficacy and safety of fingolimod (FTY720) in relapsing multiple sclerosis; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novartis | Conditions: Multiple Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2011-03-23